Hikma Pharmaceuticals Plc Total Long Term Liabilities 2016-2023 | HKMPF
Hikma Pharmaceuticals Plc total long term liabilities for the quarter ending December 31, 2023 were $1.132B, a 18.04% increase year-over-year.
- Hikma Pharmaceuticals Plc total long term liabilities for 2023 were $1.132B, a 9.15% decline from 2022.
- Hikma Pharmaceuticals Plc total long term liabilities for 2022 were $1.246B, a 40.16% increase from 2021.
- Hikma Pharmaceuticals Plc total long term liabilities for 2021 were $0.889B, a 7.3% decline from 2020.